Skip to content

effect of injectable platelet rich fibrin on treatment of thin gingival biotype

To assess and compare the efficacy of injectable platelet-rich fibrin and microneedling in treatment of thin gingival biotype A randomized controlled trial - nil

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085912
Enrollment
33
Registered
2025-04-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: INJECTABLE PLATELET RICH FIBRIN: INJECTABLE PLATELETE RICH FIBRIN IS INJECTED INTO ATTACHED GINGIVA ALONG WITH MICRONEEDLING TO INCREASE GINGIVAL BIOTYPE FOR 3 MONTHS Control Interventi

Sponsors

MANSI TAKALKAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having thin gingival biotype that is less than 1mm in maxillary anterior region. those should have plaque index score 0 or 1. those without any other dental abnormality in maxillary anterior region.

Exclusion criteria

Exclusion criteria: Patients undergoing active orthodontic treatment Patients with history of periodontal surgery Patients with history of any systemic diseases Patients on blood thinners Patients using any drugs that might lead to gingival enlargement

Design outcomes

Primary

MeasureTime frame
Gingival thicknessTimepoint: baseline, 1 month, 3 months

Secondary

MeasureTime frame
keratinized tissue widthTimepoint: baseline, 1 month, 3 months

Countries

India

Contacts

Public ContactMANSI TAKALKAR

KAHERS KLE VK Institute of dental sciences

mstakalkar1997@gmail.com8007947722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026